FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill

Links shared publicly online about this topic.

  • 2,077
    total visits

FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill

novartis.com

Basel, 30 April, 2009 - The US Food and Drug Administration (FDA) has approved Exforge HCT, the only single pill to combine the three most prescribed high blood pressure treatments in their classes in the US[3]: the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan, and the diuretic hydrochlorothiazide. Exforge HCT is an important new option for patients who have tried taking dual combinations of these classes of blood pressure medications without success.

View full resource at novartis.com

Tags: Mineral, Calcium, Drug, FDA, Calcium Channel Blocker, Norvasc, Diovan, Amlodin

  • Share

Most Recently Shared on April 30, 2009 at 8:57 pm By:

Novartis Novartis

FDA approves Exforge HCT® - the only high blood pressure treatment to combine three medications in a single pill: http://twurl.nl/rwohsw

3 years ago...

Advertisement